AA
BIIB icon

Alta Advisers’s Biogen BIIB Stock Holding History

Alta Advisers’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-500
Closed -$96.9K – 179
2024
Q3 		$96.9K Hold
500
– – 0.04% 305
2024
Q2 		$116K Hold
500
– – 0.06% 225
2024
Q1 		$108K Hold
500
– – 0.05% 258
2023
Q4 		$129K Hold
500
– – 0.07% 193
2023
Q3 		$129K Hold
500
– – 0.07% 169
2023
Q2 		$142K Hold
500
– – 0.08% 157
2023
Q1 		$139K Hold
500
– – 0.08% 155
2022
Q4 		$138K Hold
500
– – 0.08% 149
2022
Q3 		$134K Buy
+500
New +$106K 0.08% 144

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Alta Advisers's BIIB Position: Q4 2024 in Review

Alta Advisers sold out of Biogen (BIIB) in Q4 2024, closing a stake of 500 shares — an estimated $96.9K sold.

Alta Advisers first reported a position in BIIB in Q3 2022 and held it in 9 quarters. The position peaked at $142K in Q2 2023. 876 funds tracked by Wall St. Rank hold BIIB as of Q4 2024.

  • Alta Advisers reported no remaining Biogen position as of Q4 2024 after selling out during the quarter.
  • Alta Advisers sold 500 Biogen shares in Q4 2024, an estimated $96.9K.
  • Alta Advisers first reported a position in Biogen in Q3 2022 and held it in 9 quarters.
  • Alta Advisers's Biogen position peaked at $142K in Q2 2023.
  • 876 funds tracked by Wall St. Rank held Biogen as of Q4 2024.

Based on Alta Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.